Trump’s cancer plan prioritizes early detection and prevention
President Trump's administration is prioritizing earlier cancer detection and prevention through a comprehensive agenda, aiming to shift the national strategy from treating the disease after onset to proactive screening and lifestyle changes. The administration highlights support for multi-cancer early detection tests like Galleri, which can identify cancer signals in the blood before symptoms appear, potentially aiding in hard-to-detect cancers such as pancreatic and ovarian. Legislation signed this year could expand Medicare access to such technology upon FDA approval. Additionally, the FDA’s National Priority Voucher Program, launched last year, expedites approval for new American-made medicines, including a targeted therapy for metastatic pancreatic cancer approved months early. The agenda also emphasizes lifestyle factors like diet and exercise through the Make America Healthy Again movement.